The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

CVS Health Corp

NYSE: CVS
Last

(U.S.) $78.85

Today's change+0.09 +0.11%
Updated March 30 4:01 PM EDT. Delayed by at least 15 minutes.
 

CVS Health Corp

NYSE: CVS
Last

(U.S.) $78.85

Today's change+0.09 +0.11%
Updated March 30 4:01 PM EDT. Delayed by at least 15 minutes.

CVS Health Corp up (U.S.)$0.09

CVS Health Corp closed up Thursday by (U.S.)$0.09 or 0.11% to (U.S.)$78.85. Over the last five days, shares have gained 0.70%, but are currently unchanged over the last year to date. Shares have underperformed the S&P 500 by 38.95% during the last year.

Key company metrics

  • Open(U.S.) $78.65
  • Previous close(U.S.) $78.76
  • High(U.S.) $79.11
  • Low(U.S.) $78.44
  • Bid / Ask(U.S.) $78.60 / (U.S.) $79.10
  • YTD % change-0.076%
  • Volume3,834,587
  • Average volume (10-day)6,968,491
  • Average volume (1-month)6,184,283
  • Average volume (3-month)7,255,803
  • 52-week range(U.S.) $69.30 to (U.S.) $106.67
  • Beta0.84
  • Trailing P/E16.00×
  • P/E 1 year forward13.43×
  • Forward PEG1.28×
  • Indicated annual dividend(U.S.) $2.00
  • Dividend yield2.54%
  • Trailing EPS(U.S.) $4.93
Updated March 30 4:01 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.50%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Retail - Drugs

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue45,97144,61543,72543,215
Total other revenue--------
Total revenue45,97144,61543,72543,215
Gross profit7,6067,4927,0156,744
Total cost of revenue38,36537,12336,71036,471
Total operating expense42,97641,89941,91741,039
Selling / general / administrative4,6114,6754,6654,568
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)0101542--
Other operating expenses, total--------
Operating income2,9952,7161,8082,176
Interest income (expense), net non-operating-248-258-284-288
Gain (loss) on sale of assets--------
Other--------
Income before tax2,7532,4631,5281,893
Income after tax1,7071,5429241,147
Income tax, total1,046921604746
Net income1,7071,5409241,146
Total adjustments to net income-9-6-4-6
Net income before extra. items1,7071,5419241,146
Minority interest0-10-1
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1,6981,5359201,140
Inc. avail. to common incl. extra. items1,6981,5349201,140
Diluted net income1,6981,5349241,140
Dilution adjustment----4--
Diluted weighted average shares1,0701,0731,0751,099
Diluted EPS excluding extraordinary itemsvalue per share1.591.430.861.04
Dividends per sharevalue per share0.430.430.430.43
Diluted normalized EPSvalue per share1.591.491.161.04